Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community

Armour, Carol; Bosnic-Anticevich, Sinthua; Brillant, Martha; Burton, Debbie; Emmerton, Lynne; Krass, Ines; Saini, Bandana; Smith, Lorraine; Stewart, Kay
June 2007
Thorax;Jun2007, Vol. 62 Issue 6, p496
Academic Journal
Background: Despite national disease management plans, optimal asthma management remains a challenge in Australia. Community pharmacists are ideally placed to implement new strategies that aim to ensure asthma care meets current standards of best practice. The impact of the Pharmacy Asthma Care Program (PACP) on asthma control was assessed using a multi-site randomised intervention versus control repeated measures study design. Methods: Fifty Australian pharmacies were randomised into two groups: intervention pharmacies implemented the PACP (an ongoing cycle of assessment, goal setting, monitoring and review) to 191 patients over 6 months, while control pharmacies gave their usual care to 205 control patients. Both groups administered questionnaires and conducted spirometric testing at baseline and 6 months later. The main outcome measure was asthma severity/control status. Results: 186 of 205 control patients (91%) and 165 of 191 intervention patients (86%) completed the study. The intervention resulted in improved asthma control: patients receiving the intervention were 2.7 times more likely to improve from "severe" to "not severe" than control patients (OR 2.68, 95% CI 1 .64 to 4.37; p<0.001). The intervention also resulted in improved adherence to preventer medication (OR 1 .89, 95% Cl 1 .08 to 3.30; p = 0.03), decreased mean daily dose of reliever medication (difference -149.11 µg, 95% Cl -283.87 to -14.36; p = 0.03), a shift in medication profile from reliever only to a combination of preventer, reliever with or without long-acting β agonist (OR 3.80, 95% CI 1.40 to 10.32; p=0.01) and improved scores on risk of non-adherence (difference -0.44, 95% CI -0.69 to -0.18; p=0.04), quality of life (difference -0.23, 95% Cl -0.46 to 0.00; p=0.05), asthma knowledge (difference 1.18, 95% CI 0.73 to 1 .63; p<0.01) and perceived control of asthma questionnaires (difference -1.39, 95% CI -2.44 to -0.35; p<0.01). No significant change in spirometric measures occurred in either group. Conclusions: A pharmacist-delivered asthma care programme based on national guidelines improves asthma control. The sustainability and implementation of the programme within the healthcare system remains to be investigated.


Related Articles

  • The Burden of Asthma and Chronic Obstructive Pulmonary Disease: Data from The Netherlands. Rutten van-Mölken, M.P.M.H.; Feenstra, T.L. // PharmacoEconomics;Oct2001 Supplement 2, Vol. 19 Issue 10, p1 

    It is important to consider all aspects of the burden of a disease using a range of outcome measures - not only morbidity and mortality - but also the effect on patient lifestyle and healthcare resources, and the economic impact on the patient, healthcare system and society. Only with this...

  • The Role of the PBM in Total Health Management Strategies for Individuals With Chronic Conditions. Slezak, Julie; Stine, Neal // Benefits Quarterly;2003 First Quarter, Vol. 19 Issue 1, p38 

    In this article, we examine the multiple data sources and outcomes surrounding the management of both pharmacy and medical cost spending for chronic health care in one pharmacy benefit manager (PBM). We offer examples of how the complex relationship between interventions and spending is utilized...

  • An exploration of clinical interventions provided by pharmacists within a complex asthma service. LEMAY, Kate S.; SAINI, Bandana; BOSNIC-ANTICEVICH, Sinthia; SMITH, Lorraine; STEWART, Kay; EMMERTON, Lynne; BURTON, Deborah L.; KRASS, Ines; ARMOUR, Carol L. // Pharmacy Practice (1886-3655);Jan-Mar2015, Vol. 13 Issue 1, p1 

    Background: Pharmacists in Australia are accessible health care professionals, and their provision of clinical pharmacy interventions in a range of areas has been proven to improve patient outcomes. Individual clinical pharmacy interventions in the area of asthma management have been very...

  • Further Development of Pharmacy Student-Facilitated Diabetes Management Clinics. Nuffer, Wesley; McCollum, Marianne; Ellis, Samuel L.; Turner, Christopher J. // American Journal of Pharmaceutical Education;2012, Vol. 76 Issue 3, p1 

    Objective. To further develop and evaluate a diabetes disease state management (DSM) program that provided direct patient care responsibilities to advanced pharmacy practice experience (APPE) students as members of healthcare teams. Design. Nine new clinics and 3 established sites that provide...

  • Medication therapy management: Its relationship to patient counseling, disease management, and pharmaceutical care. McGivney, Melissa Somma; Mayer, Susan M.; Duncan-Hewitt, Wendy; Hall, Daanne L.; Goode, Jean-Venable R.; Smith, Randall B. // Journal of the American Pharmacists Association: JAPhA;Sep/Oct2007, Vol. 47 Issue 5, p620 

    Objective: To delineate the relationship, including similarities and differences, between medication therapy management (MTM) and contemporary pharmacist-provided services, including patient counseling, disease management, and pharmaceutical care, to facilitate the continued evolution of...

  • Walgreens Unveils Success of Medication Adherence Programs through Improved Patient Adherence and Outcomes.  // Biomedical Market Newsletter;4/28/2012, Vol. 21, p1 

    The article presents information on the release of new research results by Walgreens Co. at the Academy of Managed Care Pharmacy's 24th Annual Meeting and Exposition that was held in San Francisco from April 18-20, 2012. Walgreen Co. discussed diverse set of pharmacy programs for improving...

  • Home visits improve asthma control in adults. Mayor, Susan // BMJ: British Medical Journal;11/29/2014, Vol. 349 Issue 7895, pg7165 

    The article discusses the results of a U.S. study on the benefits of greater support for self management revealing that low income adult patients with uncontrolled asthma who had home visits from community health workers had two more symptom-free days in every two weeks.

  • Impacts of a Government-Sponsored Outpatient-Based Disease Management Program for Patients with Asthma: A Preliminary Analysis of National Data from Taiwan. Weng, Hui-Ching // Disease Management;Feb2005, Vol. 8 Issue 1, p48 

    In response to the high prevalence rates, mortality rates, and rising medical cost of asthma, the Bureau of National Health Insurance (BNHI) initiated a Healthcare Quality Improvement Program (HQIP) for people with asthma. The aim of this study was to investigate a preliminary analysis of the...

  • Implementing supported self-management for asthma: a systematic reviewand suggested hierarchy of evidence of implementation studies. Pinnock, Hilary; Epiphaniou, Eleni; Pearce, Gemma; Parke, Hannah; Greenhalgh, Trish; Sheikh, Aziz; Griffiths, Chris J.; Taylor, Stephanie J. C. // BMC Medicine;2015, Vol. 13 Issue 1, p1 

    Background: Asthma self-management remains poorly implemented in clinical practice despite overwhelming evidence of improved healthcare outcomes, reflected in guideline recommendations over three decades. To inform delivery in routine care, we synthesised evidence from implementation studies of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics